Blisce

Investment focus

Blisce's portfolio on More Capital spans food & agriculture, healthcare & biotech. The firm is based in Paris, Île-de-France, France. Of the 2 portfolio companies tracked here, 1 have publicly reported valuations totaling approximately $1B.

If your company is backed by Blisce

Employees at companies backed by Blisce may encounter this fund's name on their cap table, in board communications, or in funding announcements. Understanding who invests in your employer can provide useful context when evaluating your equity.

What this means for your stock

Institutional investors like Blisce typically hold preferred shares with rights that differ from the common stock or options held by employees. In a liquidity event, preferred shareholders may have liquidation preferences, anti-dilution protections, or board-level governance rights that affect the value of common equity. The specific terms depend on each company's funding agreements.

Secondary market considerations

Some venture-backed companies allow employees to sell shares on secondary markets, while others restrict transfers. Whether your company permits secondary sales, and under what conditions, is typically governed by the company's equity plan and any applicable right-of-first-refusal provisions — not by the fund itself. However, the presence of institutional investors can sometimes signal the maturity and governance structure of the company.

Blisce portfolio companies

2 companies tracked on More Capital, sorted by reported valuation. 1 companies do not have a publicly reported valuation.

Top holdings by valuation

By sector

Industries invested in

• Food & Agriculture
• Healthcare & Biotech

Frequent co-investors

Funds that most frequently co-invest alongside Blisce in the same companies.